Related Experiment Video
Updated: Aug 23, 2026

Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
Stability and compatibility of tegaserod from crushed tablets mixed in beverages and foods
Marie-Noëlle Carrier1, Olivier Garinot, Christian Vitzling
1Department of Bioanalytics and Pharmacokinetics, Novartis Pharma SAS, Rueil-Malmaison, France.
Purpose:
The stability and compatibility of tegaserod from crushed tablets in selected beverages and foods were studied.
Methods:
Suspensions of tegaserod maleate tablets containing 6 mg of the drug base were prepared by crushing the tablets and mixing the powder with tap water, apple juice, orange juice, milk, applesauce, yogurt, and chocolate-hazelnut spread. Drug stability, drug comparability, suspension homogeneity, and completeness of a dose were measured by high-performance liquid chromatography at intervals up to three days at 20-25 degrees C and 5 degrees C. In vitro dissolution profiles were determined for crushed tegaserod tablets in water, apple juice, orange juice, and applesauce.
Results:
Tegaserod from crushed tablets was stable in and compatible with water, apple juice, orange juice, and applesauce, and the suspensions were homogeneous. The complete dose was delivered with these media. The dissolution profiles of crushed tegaserod tablets in water and in apple juice were comparable to those of intact tablets; the dissolution profiles in orange juice and applesauce were not comparable with those of intact tablets. The results with milk, yogurt, and chocolate-hazelnut spread as vehicles were inconclusive. The suspension in milk was not homogeneous, and the dose was incomplete.
Conclusion:
Tegaserod from crushed tablets was stable in and compatible with water, apple juice, orange juice, and applesauce, but the dissolution profile in orange juice or applesauce was not acceptable. Apple juice may be the preferred vehicle because it masks the drug's taste.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Product Stability
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Modified-Release Drug Delivery Systems: Overview
